{
    "items": [
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/moa-develops-groundbreaking-category-of-crop-protection-signs-partnership-deal-with-gowan?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/moa-develops-groundbreaking-category-of-crop-protection-signs-partnership-deal-with-gowan/responsive_image?ratio=r16x9&amp;v=1756907875000&amp;scale=w760\" alt=\"A crop field\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/moa-develops-groundbreaking-category-of-crop-protection-signs-partnership-deal-with-gowan/responsive_image?ratio=r16x9&amp;v=1756907875000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/moa-develops-groundbreaking-category-of-crop-protection-signs-partnership-deal-with-gowan/responsive_image?ratio=r16x9&amp;v=1756907875000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/moa-develops-groundbreaking-category-of-crop-protection-signs-partnership-deal-with-gowan/responsive_image?ratio=r16x9&amp;v=1756907875000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/moa-develops-groundbreaking-category-of-crop-protection-signs-partnership-deal-with-gowan\" title=\"OXFORD UK: Moa Technology today announces its discovery of chemistries which could become an entirely new category of products to help farmers protect their harvests more safely, sustainably and effectively.\" itemprop=\"name\" class=\"state-published\">Moa develops groundbreaking category of crop protection; signs partnership deal with Gowan</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">26 Aug, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">OXFORD UK: Moa Technology today announces its discovery of chemistries which could become an entirely new category of products to help farmers protect their harvests more safely, sustainably and effectively.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://iuk-business-connect.org.uk/casestudy/harnessing-the-power-of-cancer-killing-viruses/?ref=image\" title=\"\" target=\"_blank\" rel=\"noopener external\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/theolytics-doses-first-patient-in-phase-i-iia-trial-of-theo-260-in-ovarian-cancer-1/responsive_image?ratio=r16x9&amp;v=1732790240000&amp;scale=w760\" alt=\"A model of the uterus.\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/theolytics-doses-first-patient-in-phase-i-iia-trial-of-theo-260-in-ovarian-cancer-1/responsive_image?ratio=r16x9&amp;v=1732790240000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/theolytics-doses-first-patient-in-phase-i-iia-trial-of-theo-260-in-ovarian-cancer-1/responsive_image?ratio=r16x9&amp;v=1732790240000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/theolytics-doses-first-patient-in-phase-i-iia-trial-of-theo-260-in-ovarian-cancer-1/responsive_image?ratio=r16x9&amp;v=1732790240000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://iuk-business-connect.org.uk/casestudy/harnessing-the-power-of-cancer-killing-viruses/\" title=\"Theolytics has created an extensive proprietary library of oncolytic viruses (viruses that kill cancer cells) to harness their potential to safely target and destroy tumour cells while leaving healthy cells intact.\" itemprop=\"name\" class=\"state-published\" target=\"_blank\" rel=\"noopener external\">Theolytics featured in Innovate UK Case Study: Harnessing the power of cancer-killing viruses</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">7 Aug, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Theolytics has created an extensive proprietary library of oncolytic viruses (viruses that kill cancer cells) to harness their potential to safely target and destroy tumour cells while leaving healthy cells intact.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/omass-therapeutics-appoints-carol-a-schafer-as-non-executive-director-and-chair-of-the-audit-committee?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/omass-therapeutics-appoints-carol-a-schafer-as-non-executive-director-and-chair-of-the-audit-committee/responsive_image?ratio=r16x9&amp;v=1756908080000&amp;scale=w760\" alt=\"Carol A. Schafer\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/omass-therapeutics-appoints-carol-a-schafer-as-non-executive-director-and-chair-of-the-audit-committee/responsive_image?ratio=r16x9&amp;v=1756908080000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/omass-therapeutics-appoints-carol-a-schafer-as-non-executive-director-and-chair-of-the-audit-committee/responsive_image?ratio=r16x9&amp;v=1756908080000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/omass-therapeutics-appoints-carol-a-schafer-as-non-executive-director-and-chair-of-the-audit-committee/responsive_image?ratio=r16x9&amp;v=1756908080000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/omass-therapeutics-appoints-carol-a-schafer-as-non-executive-director-and-chair-of-the-audit-committee\" title=\"OMass Therapeutics (\u2018OMass\u2019 or \u2018the Company\u2019), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces the appointment of Carol A. Schafer as non-executive Director and Chair of the Audit Committee.\" itemprop=\"name\" class=\"state-published\">OMass Therapeutics appoints Carol A. Schafer as Non-Executive Director and Chair of the Audit Committee</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">6 Aug, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">OMass Therapeutics (\u2018OMass\u2019 or \u2018the Company\u2019), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces the appointment of Carol A. Schafer as non-executive Director and Chair of the Audit Committee.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/biotech-start-up-ochre-bio-relocates-to-alexandria-center-r-for-life-science-2013-new-york-city?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/biotech-start-up-ochre-bio-relocates-to-alexandria-center-r-for-life-science-2013-new-york-city/responsive_image?ratio=r16x9&amp;v=1755520392000&amp;scale=w760\" alt=\"A moving van outside of a glass-fronted building\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/biotech-start-up-ochre-bio-relocates-to-alexandria-center-r-for-life-science-2013-new-york-city/responsive_image?ratio=r16x9&amp;v=1755520392000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/biotech-start-up-ochre-bio-relocates-to-alexandria-center-r-for-life-science-2013-new-york-city/responsive_image?ratio=r16x9&amp;v=1755520392000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/biotech-start-up-ochre-bio-relocates-to-alexandria-center-r-for-life-science-2013-new-york-city/responsive_image?ratio=r16x9&amp;v=1755520392000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/biotech-start-up-ochre-bio-relocates-to-alexandria-center-r-for-life-science-2013-new-york-city\" title=\"JLL announced today that it has completed a sublease for growing U.K.-based biotech company Ochre Bio at 430 East 29th St. within the Alexandria Center\u00ae for Life Science \u2013 New York City.\" itemprop=\"name\" class=\"state-published\">Biotech start-up Ochre Bio relocates to Alexandria Center\u00ae for Life Science \u2013 New York City</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">21 Jul, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">JLL announced today that it has completed a sublease for growing U.K.-based biotech company Ochre Bio at 430 East 29th St. within the Alexandria Center\u00ae for Life Science \u2013 New York City.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/omass-therapeutics-presents-positive-preclinical-data-for-its-best-in-class-mc2-program-at-endo-2025?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/omass-therapeutics-presents-positive-preclinical-data-for-its-best-in-class-mc2-program-at-endo-2025/responsive_image?ratio=r16x9&amp;v=1753100263000&amp;scale=w760\" alt=\"A scientist inputting data on a laptop\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/omass-therapeutics-presents-positive-preclinical-data-for-its-best-in-class-mc2-program-at-endo-2025/responsive_image?ratio=r16x9&amp;v=1753100263000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/omass-therapeutics-presents-positive-preclinical-data-for-its-best-in-class-mc2-program-at-endo-2025/responsive_image?ratio=r16x9&amp;v=1753100263000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/omass-therapeutics-presents-positive-preclinical-data-for-its-best-in-class-mc2-program-at-endo-2025/responsive_image?ratio=r16x9&amp;v=1753100263000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/omass-therapeutics-presents-positive-preclinical-data-for-its-best-in-class-mc2-program-at-endo-2025\" title=\"OMass Therapeutics (\u2018OMass\u2019 or \u2018the Company\u2019), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces positive preclinical data for OMS1620, its lead program targeting the melanocortin-2 (MC2) receptor, at ENDO 2025, the Annual Endocrine Society Meeting, taking place in San Francisco from 12-15 July.\" itemprop=\"name\" class=\"state-published\">OMass Therapeutics presents positive preclinical data for its Best-in-class MC2 program at ENDO 2025</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">14 Jul, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">OMass Therapeutics (\u2018OMass\u2019 or \u2018the Company\u2019), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces positive preclinical data for OMS1620, its lead program targeting the melanocortin-2 (MC2) receptor, at ENDO 2025, the Annual Endocrine Society Meeting, taking place in San Francisco from 12-15 July.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/dr-quin-wills-appointed-as-ochre-bio-ceo?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/quin-wills-ceo/responsive_image?ratio=r16x9&amp;v=1756908205000&amp;scale=w760\" alt=\"Quin Wills, CEO, Ochre Bio\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/quin-wills-ceo/responsive_image?ratio=r16x9&amp;v=1756908205000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/quin-wills-ceo/responsive_image?ratio=r16x9&amp;v=1756908205000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/quin-wills-ceo/responsive_image?ratio=r16x9&amp;v=1756908205000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/dr-quin-wills-appointed-as-ochre-bio-ceo\" title=\"Oxford-based Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, has appointed Dr Quin Wills as CEO.\" itemprop=\"name\" class=\"state-published\">Dr Quin Wills appointed as Ochre Bio CEO</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">30 Jun, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Oxford-based Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, has appointed Dr Quin Wills as CEO.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/ochre-bio-appoints-ex-eli-lilly-and-astrazeneca-vp-as-non-executive-director?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/ochre-bio-appoints-ex-eli-lilly-and-astrazeneca-vp-as-non-executive-director/responsive_image?ratio=r16x9&amp;v=1748872531000&amp;scale=w760\" alt=\"Photo of Dr Elaine Sullivan\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/ochre-bio-appoints-ex-eli-lilly-and-astrazeneca-vp-as-non-executive-director/responsive_image?ratio=r16x9&amp;v=1748872531000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/ochre-bio-appoints-ex-eli-lilly-and-astrazeneca-vp-as-non-executive-director/responsive_image?ratio=r16x9&amp;v=1748872531000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/ochre-bio-appoints-ex-eli-lilly-and-astrazeneca-vp-as-non-executive-director/responsive_image?ratio=r16x9&amp;v=1748872531000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/ochre-bio-appoints-ex-eli-lilly-and-astrazeneca-vp-as-non-executive-director\" title=\"The appointment and ongoing science team expansion will help the company advance late-stage liver disease therapeutics.\" itemprop=\"name\" class=\"state-published\">Ochre Bio appoints ex-Eli Lilly and AstraZeneca VP as Non-Executive Director</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">29 May, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">The appointment and ongoing science team expansion will help the company advance late-stage liver disease therapeutics.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/pepgen-to-focus-on-development-of-promising-dm1-program-following-10-mg-kg-pgn-edo51-update?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/pepgen-to-focus-on-development-of-promising-dm1-program-following-10-mg-kg-pgn-edo51-update/responsive_image?ratio=r16x9&amp;v=1751372983000&amp;scale=w760\" alt=\"A drawing of a path that splits into two\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/pepgen-to-focus-on-development-of-promising-dm1-program-following-10-mg-kg-pgn-edo51-update/responsive_image?ratio=r16x9&amp;v=1751372983000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/pepgen-to-focus-on-development-of-promising-dm1-program-following-10-mg-kg-pgn-edo51-update/responsive_image?ratio=r16x9&amp;v=1751372983000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/pepgen-to-focus-on-development-of-promising-dm1-program-following-10-mg-kg-pgn-edo51-update/responsive_image?ratio=r16x9&amp;v=1751372983000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/pepgen-to-focus-on-development-of-promising-dm1-program-following-10-mg-kg-pgn-edo51-update\" title=\"PGN-EDO51 did not achieve target dystrophin levels in CONNECT1-EDO51 trial; Company to discontinue development of DMD programs. PGN-EDO51 at 10 mg/kg was generally well tolerated; all treatment-related adverse events were mild. DM1 program on track to read out FREEDOM-DM1 15 mg/kg cohort in second half of 2025 and FREEDOM2-DM1 5 mg/kg cohort in Q1 2026.\" itemprop=\"name\" class=\"state-published\">PepGen to focus on development of promising DM1 program following 10 mg/kg PGN-EDO51 update</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">28 May, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">PGN-EDO51 did not achieve target dystrophin levels in CONNECT1-EDO51 trial; Company to discontinue development of DMD programs. PGN-EDO51 at 10 mg/kg was generally well tolerated; all treatment-related adverse events were mild. DM1 program on track to read out FREEDOM-DM1 15 mg/kg cohort in second half of 2025 and FREEDOM2-DM1 5 mg/kg cohort in Q1 2026.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/nucleome-therapeutics-appoints-bhavna-hunjan-as-chief-business-officer?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/nucleome/responsive_image?ratio=r16x9&amp;v=1748872413000&amp;scale=w760\" alt=\"Photo of Bhavna Hunjan\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/nucleome/responsive_image?ratio=r16x9&amp;v=1748872413000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/nucleome/responsive_image?ratio=r16x9&amp;v=1748872413000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/nucleome/responsive_image?ratio=r16x9&amp;v=1748872413000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/nucleome-therapeutics-appoints-bhavna-hunjan-as-chief-business-officer\" title=\"Nucleome Therapeutics (\u2018Nucleome\u2019 or \u2018the Company\u2019), a biotechnology company harnessing the power of non-coding human genetics to discover first-in-class antibody treatments for inflammatory diseases, announces it has appointed Bhavna Hunjan as Chief Business Officer with immediate effect.\" itemprop=\"name\" class=\"state-published\">Nucleome Therapeutics appoints Bhavna Hunjan as Chief Business Officer</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">27 May, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Nucleome Therapeutics (\u2018Nucleome\u2019 or \u2018the Company\u2019), a biotechnology company harnessing the power of non-coding human genetics to discover first-in-class antibody treatments for inflammatory diseases, announces it has appointed Bhavna Hunjan as Chief Business Officer with immediate effect.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/pepgen-appoints-kasra-kasraian-phd-as-chief-technology-officer?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/pepgen-cto-appointment/responsive_image?ratio=r16x9&amp;v=1747849959000&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/pepgen-cto-appointment/responsive_image?ratio=r16x9&amp;v=1747849959000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/pepgen-cto-appointment/responsive_image?ratio=r16x9&amp;v=1747849959000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/pepgen-cto-appointment/responsive_image?ratio=r16x9&amp;v=1747849959000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/pepgen-appoints-kasra-kasraian-phd-as-chief-technology-officer\" title=\"PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointment of Kasra Kasraian, PhD, as Chief Technology Officer (CTO). Dr. Kasraian brings over 25 years of experience in product and process development, CMC strategy, and technical operations, spanning small and large molecules, as well as cell and gene therapies.\" itemprop=\"name\" class=\"state-published\">PepGen appoints Kasra Kasraian, PhD, as Chief Technology Officer</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">20 May, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointment of Kasra Kasraian, PhD, as Chief Technology Officer (CTO). Dr. Kasraian brings over 25 years of experience in product and process development, CMC strategy, and technical operations, spanning small and large molecules, as well as cell and gene therapies.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/alchemab-therapeutics-signs-landmark-415m-licensing-agreement-for-atlx-1282-with-eli-lilly-and-company?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/alchemab-lilly/responsive_image?ratio=r16x9&amp;v=1747050293000&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/alchemab-lilly/responsive_image?ratio=r16x9&amp;v=1747050293000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/alchemab-lilly/responsive_image?ratio=r16x9&amp;v=1747050293000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/alchemab-lilly/responsive_image?ratio=r16x9&amp;v=1747050293000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/alchemab-therapeutics-signs-landmark-415m-licensing-agreement-for-atlx-1282-with-eli-lilly-and-company\" title=\"Alchemab Therapeutics (Alchemab), the next generation biopharmaceutical company which uses the power of human immune evolution to identify and develop naturally occurring therapeutic antibodies from resilient individuals, today announces that it has entered into a licensing agreement with Eli Lilly and Company (Lilly) for ATLX-1282, Alchemab\u2019s first-in-class IND-ready programme for amyotrophic lateral sclerosis (ALS) and other neurodegenerative conditions.\" itemprop=\"name\" class=\"state-published\">Alchemab Therapeutics signs landmark $415m licensing agreement for ATLX-1282 with Eli Lilly and Company</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">6 May, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Alchemab Therapeutics (Alchemab), the next generation biopharmaceutical company which uses the power of human immune evolution to identify and develop naturally occurring therapeutic antibodies from resilient individuals, today announces that it has entered into a licensing agreement with Eli Lilly and Company (Lilly) for ATLX-1282, Alchemab\u2019s first-in-class IND-ready programme for amyotrophic lateral sclerosis (ALS) and other neurodegenerative conditions.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/enara-bio-strengthens-senior-leadership-with-key-executive-and-board-appointments-alongside-acceleration-of-multiple-t-cell-engager-programs?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/enara-bio-strengthens-senior-leadership-with-key-executive-and-board-appointments-alongside-acceleration-of-multiple-t-cell-engager-programs/responsive_image?ratio=r16x9&amp;v=1746521540000&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/enara-bio-strengthens-senior-leadership-with-key-executive-and-board-appointments-alongside-acceleration-of-multiple-t-cell-engager-programs/responsive_image?ratio=r16x9&amp;v=1746521540000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/enara-bio-strengthens-senior-leadership-with-key-executive-and-board-appointments-alongside-acceleration-of-multiple-t-cell-engager-programs/responsive_image?ratio=r16x9&amp;v=1746521540000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/enara-bio-strengthens-senior-leadership-with-key-executive-and-board-appointments-alongside-acceleration-of-multiple-t-cell-engager-programs/responsive_image?ratio=r16x9&amp;v=1746521540000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/enara-bio-strengthens-senior-leadership-with-key-executive-and-board-appointments-alongside-acceleration-of-multiple-t-cell-engager-programs\" title=\"Enara Bio, a biopharmaceutical company pioneering the development of bispecific T-cell engagers directed against Dark Antigen\u00ae and other emerging targets, today announces the appointment of Stacey Davis as Chief Business Officer (CBO) and Chief Financial Officer (CFO). Her appointment strengthens the leadership team at a key moment for Enara as it prepares to transition its lead assets towards clinical development. Stacey most recently served as CBO at Xilio Therapeutics, where she was the architect of a series of major pharma collaborations. In total, Stacey brings over 25 years of experience in delivering growth, innovation, and strategic transformation in the biotech and pharmaceutical industries.\" itemprop=\"name\" class=\"state-published\">Enara Bio strengthens senior leadership with key Executive and Board appointments alongside acceleration of multiple T-Cell engager programs</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">1 May, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Enara Bio, a biopharmaceutical company pioneering the development of bispecific T-cell engagers directed against Dark Antigen\u00ae and other emerging targets, today announces the appointment of Stacey Davis as Chief Business Officer (CBO) and Chief Financial Officer (CFO). Her appointment strengthens the leadership team at a key moment for Enara as it prepares to transition its lead assets towards clinical development. Stacey most recently served as CBO at Xilio Therapeutics, where she was the architect of a series of major pharma collaborations. In total, Stacey brings over 25 years of experience in delivering growth, innovation, and strategic transformation in the biotech and pharmaceutical industries.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/pepgen-announces-appointment-of-two-new-directors-to-its-board?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/pepgen/responsive_image?ratio=r16x9&amp;v=1748872120000&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/pepgen/responsive_image?ratio=r16x9&amp;v=1748872120000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/pepgen/responsive_image?ratio=r16x9&amp;v=1748872120000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/pepgen/responsive_image?ratio=r16x9&amp;v=1748872120000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/pepgen-announces-appointment-of-two-new-directors-to-its-board\" title=\"PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointments of Lisa Wyman and Mitchell H. Finer, PhD, to its Board of Directors. Ms. Wyman and Dr. Finer are industry veterans, each bringing decades of executive experience in the life sciences to the Company.\" itemprop=\"name\" class=\"state-published\">PepGen announces appointment of two new directors to its Board</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">31 Mar, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced the appointments of Lisa Wyman and Mitchell H. Finer, PhD, to its Board of Directors. Ms. Wyman and Dr. Finer are industry veterans, each bringing decades of executive experience in the life sciences to the Company.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/moa-named-one-of-times-top-greentech-companies-in-2025?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/tenant-logos/moa-technology.png/responsive_image?ratio=r16x9&amp;v=1751017554000&amp;scale=w760\" alt=\"MoA Technology logo\" srcset=\"https://www.bioescalator.ox.ac.uk/images/tenant-logos/moa-technology.png/responsive_image?ratio=r16x9&amp;v=1751017554000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/tenant-logos/moa-technology.png/responsive_image?ratio=r16x9&amp;v=1751017554000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/tenant-logos/moa-technology.png/responsive_image?ratio=r16x9&amp;v=1751017554000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/moa-named-one-of-times-top-greentech-companies-in-2025\" title=\"Moa recognised as leading global innovator in environmental impact.\" itemprop=\"name\" class=\"state-published\">Moa named one of TIME's top greentech companies in 2025</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">26 Mar, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Moa recognised as leading global innovator in environmental impact.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/moa-technology-forms-new-biological-partnership-with-naicons?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/moa/responsive_image?ratio=r16x9&amp;v=1748872149000&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/moa/responsive_image?ratio=r16x9&amp;v=1748872149000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/moa/responsive_image?ratio=r16x9&amp;v=1748872149000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/moa/responsive_image?ratio=r16x9&amp;v=1748872149000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/moa-technology-forms-new-biological-partnership-with-naicons\" title=\"Moa and NAICONS join forces to discover the next generation of naturally-occurring herbicides.\" itemprop=\"name\" class=\"state-published\">Moa forms new biological partnership with NAICONS</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">25 Mar, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Moa and NAICONS join forces to discover the next generation of naturally-occurring herbicides.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/omass-therapeutics-appoints-birgitte-volck-as-non-executive-director?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/omass-therapeutics-appoints-birgitte-volck-as-non-executive-director/responsive_image?ratio=r16x9&amp;v=1741085809000&amp;scale=w760\" alt=\"A photo of Dr Birgitte Volck\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/omass-therapeutics-appoints-birgitte-volck-as-non-executive-director/responsive_image?ratio=r16x9&amp;v=1741085809000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/omass-therapeutics-appoints-birgitte-volck-as-non-executive-director/responsive_image?ratio=r16x9&amp;v=1741085809000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/omass-therapeutics-appoints-birgitte-volck-as-non-executive-director/responsive_image?ratio=r16x9&amp;v=1741085809000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/omass-therapeutics-appoints-birgitte-volck-as-non-executive-director\" title=\"OMass Therapeutics (\u2018OMass\u2019 or \u2018the Company\u2019), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces that Birgitte Volck MD, PhD has joined its Board as a non-executive director.\" itemprop=\"name\" class=\"state-published\">OMass Therapeutics appoints Birgitte Volck as Non-Executive Director</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">26 Feb, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">OMass Therapeutics (\u2018OMass\u2019 or \u2018the Company\u2019), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces that Birgitte Volck MD, PhD has joined its Board as a non-executive director.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/enara-bio-embarks-on-a-research-collaboration-with-george-washington-university-to-deepen-understanding-of-dark-antigen-r-biology-and-expression?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/enara-bio-embarks-on-a-research-collaboration-with-george-washington-university-to-deepen-understanding-of-dark-antigen-r-biology-and-expression/responsive_image?ratio=r16x9&amp;v=1741083453000&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/enara-bio-embarks-on-a-research-collaboration-with-george-washington-university-to-deepen-understanding-of-dark-antigen-r-biology-and-expression/responsive_image?ratio=r16x9&amp;v=1741083453000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/enara-bio-embarks-on-a-research-collaboration-with-george-washington-university-to-deepen-understanding-of-dark-antigen-r-biology-and-expression/responsive_image?ratio=r16x9&amp;v=1741083453000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/enara-bio-embarks-on-a-research-collaboration-with-george-washington-university-to-deepen-understanding-of-dark-antigen-r-biology-and-expression/responsive_image?ratio=r16x9&amp;v=1741083453000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/enara-bio-embarks-on-a-research-collaboration-with-george-washington-university-to-deepen-understanding-of-dark-antigen-r-biology-and-expression\" title=\"Collaboration may inform future combination strategies that can maximise the efficacy of Enara Bio\u2019s pipeline of TCR-based immunotherapies targeting Dark Antigens\u00ae\" itemprop=\"name\" class=\"state-published\">Enara Bio embarks on a research collaboration with George Washington University to deepen understanding of Dark Antigen\u00ae biology and expression</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">18 Feb, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">Collaboration may inform future combination strategies that can maximise the efficacy of Enara Bio\u2019s pipeline of TCR-based immunotherapies targeting Dark Antigens\u00ae</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.thetimes.com/sunday-times-100-tech?ref=image\" title=\"\" target=\"_blank\" rel=\"noopener external\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/enara-bio-growth/responsive_image?ratio=r16x9&amp;v=1738155022000&amp;scale=w760\" alt=\"Enara Bio logo\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/enara-bio-growth/responsive_image?ratio=r16x9&amp;v=1738155022000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/enara-bio-growth/responsive_image?ratio=r16x9&amp;v=1738155022000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/enara-bio-growth/responsive_image?ratio=r16x9&amp;v=1738155022000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.thetimes.com/sunday-times-100-tech\" title=\"The guide showcases Britain's fastest-growing private tech companies from The Sunday Times, commercialising innovation across the UK.  &quot;This recognition is a testament to our innovative science and the hard work of our incredible team as we strive to develop safe and effective treatments for cancer patients.&quot; Enara Bio\" itemprop=\"name\" class=\"state-published\" target=\"_blank\" rel=\"noopener external\">Enara Bio listed in the inaugural edition of The Sunday Times 100 Tech 2025</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">22 Jan, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">The guide showcases Britain's fastest-growing private tech companies from The Sunday Times, commercialising innovation across the UK.  \"This recognition is a testament to our innovative science and the hard work of our incredible team as we strive to develop safe and effective treatments for cancer patients.\" Enara Bio</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/alchemab-therapeutics-enters-into-collaboration-with-lilly-to-discover-research-and-develop-novel-therapies-for-als?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/man-in-wheelchair/responsive_image?ratio=r16x9&amp;v=1738154139000&amp;scale=w760\" alt=\"A man in a wheelchair is looking at a tree with lime-green leaves.\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/man-in-wheelchair/responsive_image?ratio=r16x9&amp;v=1738154139000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/man-in-wheelchair/responsive_image?ratio=r16x9&amp;v=1738154139000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/man-in-wheelchair/responsive_image?ratio=r16x9&amp;v=1738154139000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/alchemab-therapeutics-enters-into-collaboration-with-lilly-to-discover-research-and-develop-novel-therapies-for-als\" title=\"The agreement supports the research and development of up to five novel therapeutic antibodies identified through Alchemab's antibody discovery platform.\" itemprop=\"name\" class=\"state-published\">Alchemab Therapeutics enters into collaboration with Lilly to discover, research and develop novel therapies for ALS</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">9 Jan, 2025</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">The agreement supports the research and development of up to five novel therapeutic antibodies identified through Alchemab's antibody discovery platform.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n",
        "\n\n    <div class=\"listing-item listing-item-news\" itemscope itemprop=\"itemListElement\" itemtype=\"http://schema.org/NewsArticle\">\n\n        <div class=\"row\">\n\n            \n                <div class=\"col-xs-12 col-sm-4\" style=\"margin-bottom:10px\">\n                    \n\n    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/theolytics-appoints-david-apelian-md-phd-mba-as-ceo?ref=image\" title=\"\">\n        <figure>\n            <div class=\"image-container\">\n                \n\n    \n\n        <img src=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/theolytics-appoints-david-apelian-md-phd-mba-as-ceo/responsive_image?ratio=r16x9&amp;v=1734695410000&amp;scale=w760\" alt=\"\" srcset=\"https://www.bioescalator.ox.ac.uk/images/news-and-events/theolytics-appoints-david-apelian-md-phd-mba-as-ceo/responsive_image?ratio=r16x9&amp;v=1734695410000&amp;scale=w1140 1140w, https://www.bioescalator.ox.ac.uk/images/news-and-events/theolytics-appoints-david-apelian-md-phd-mba-as-ceo/responsive_image?ratio=r16x9&amp;v=1734695410000&amp;scale=w760 760w, https://www.bioescalator.ox.ac.uk/images/news-and-events/theolytics-appoints-david-apelian-md-phd-mba-as-ceo/responsive_image?ratio=r16x9&amp;v=1734695410000&amp;scale=w320 320w\" sizes=\"100vw\" itemprop=\"image\" itemscope=\"\" itemtype=\"http://schema.org/ImageObject\" />\n         \n    \n\n\n            </div>\n            \n        </figure>\n    </a>\n\n\n                </div>\n            \n\n            <div class=\"col-xs-12  col-sm-8\">\n\n                \n\n    <h2 class=\"media-heading\">\n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/theolytics-appoints-david-apelian-md-phd-mba-as-ceo\" title=\"David Apelian MD PhD MBA, an experienced CEO with significant development and regulatory experience in virology and immune-oncology joins Theolytics. Dr Apelian joins as the company advances its first clinical trial with lead candidate THEO-260 in ovarian cancer.\" itemprop=\"name\" class=\"state-published\">Theolytics appoints David Apelian MD, PhD, MBA as CEO</a>\n    </h2>\n\n\n\n                <p class=\"details\">\n                    \n                        <span itemprop=\"datePublished\">17 Dec, 2024</span>\n                    \n                </p>\n\n                \n                    \n\n    \n\n        <ul class=\"list-unstyled list-inline categories-list\">\n            \n            \n                <li class=\"list-inline-item\">\n                    <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?categories=alumni-news\" title=\"Alumni news\">\n                        <span class=\"badge bg-primary\">Alumni news</span>\n                    </a>\n                </li>\n            \n\n        </ul>\n\n    \n\n\n                \n\n                \n            \n                \n                    <p itemprop=\"description\">David Apelian MD PhD MBA, an experienced CEO with significant development and regulatory experience in virology and immune-oncology joins Theolytics. Dr Apelian joins as the company advances its first clinical trial with lead candidate THEO-260 in ovarian cancer.</p>\n                \n\n            </div>\n\n        </div>\n\n    </div>\n\n\n"
    ],
    "more": "\n\n    \n        <a href=\"https://www.bioescalator.ox.ac.uk/news-and-events/news/search?category=alumni-news&amp;random=447c4322-7246-4708-bdbc-f1f4f03b279b&amp;b_start:int=60&amp;format=json&amp;r=29868482\" title=\"Load more\" class=\"btn load-more-button\">\n            Load More\n        </a>\n    \n\n\n",
    "msg": ""
}